Unresectable Gallbladder Cancer Completed Phase 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028792 (Unresectable Gallbladder Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs